Navigation Links
One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
Date:9/21/2007

appetite, the amount of food eaten, and body weight. These are not all the side effects with BYETTA. A healthcare provider should be consulted about any side effect that is bothersome or does not go away.

For complete safety profile and other important prescribing considerations, visit http://www.BYETTA.com.

About Amylin and Lilly

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first- in-class medicines for diabetes. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is located in San Diego, California with over 1,700 employees nationwide.

Through a long-standing commitment to diabetes care, Lilly provides patients with breakthrough treatments that enable them to live longer, healthier and fuller lives. Since 1923, Lilly has been the industry leader in pioneering therapies to help health care professionals improve the lives of people with diabetes, and research continues on innovative medicines to address the unmet needs of patients.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Indiana, Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs.

This press release contains forward-looking statements about Amylin and Lilly. Actual results could differ materially from those discussed or implied in this press release due to a number of risks and uncertainties, including the risk that exenatide and the revenu
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... CTI BioPharma Corp. (NASDAQ and MTA: CTIC) announced today ... financial results on Thursday, August 6, 2015, after the ... members of the management team will host a webcast ... general corporate update at 4:30 p.m. EDT (1:30 p.m. ... follows: Thursday, August 6 1:30 p.m. PDT/4:30 ...
(Date:7/27/2015)... PARIS , July 28, 2015   Regeneron ... into a new global collaboration to discover, develop and ... of immuno-oncology. As part of the agreement, the two ... 1 (PD-1) inhibitor currently in Phase 1 testing and ... therapeutic candidates based on ongoing, innovative preclinical programs. ...
(Date:7/27/2015)... WESTLAKE VILLAGE, Calif. , July 27, ... and KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH ) today ... granted early termination of the waiting period under the ... respect to Allergan,s pending acquisition of KYTHERA.  ... July 6, 2015, each of Allergan and KYTHERA filed ...
Breaking Medicine Technology:CTI BioPharma to Report Second Quarter 2015 Financial Results on August 6, 2015 2Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 2Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 3Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 4Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 5Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 6Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 7Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 8Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 2Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 3Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 4Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 5Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 6Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 7Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 8Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 9
(Date:7/28/2015)... , ... July 28, 2015 , ... ... announced HeartPlace will be expanding their cloud presence to support their rapidly growing ... in North Texas, has been serving the Dallas/Fort Worth area for almost 50 ...
(Date:7/28/2015)... ... July 28, 2015 , ... Maryland Brain & Spine ... and, along with it, more service offerings, updated treatment techniques, and additional state-of-the art ... pain management and minimally invasive surgical treatment of brain and spine conditions. , ...
(Date:7/28/2015)... ... , ... Please join us for the 5th Annual Step for Hope 5K Run/Walk ... and Lies Road in Carol Stream. All are welcome. , Now in its 5th ... help to support individuals and families affected by a brain aneurysm. , “We look ...
(Date:7/28/2015)... ... ... Advanced Fertility Center of Texas (AFCT) has hosted the EMBCOL office ... a Reproductive Laboratory Director at AFCT, was one of the founders of EMBCOL and ... who is credited with the discovery of intra-cytoplasmic sperm injection (ICSI) , which ...
(Date:7/28/2015)... ... July 28, 2015 , ... One of ... Runner’s World Magazine, is plantar fasciitis . Zensah, the Miami-based compression brand, ... by a professional athletic trainer, the Zensah Ankle Support’s primary benefits include helping ...
Breaking Medicine News(10 mins):Health News:HeartPlace Announces Cloud Expansion with VAZATA 2Health News:HeartPlace Announces Cloud Expansion with VAZATA 3Health News:Maryland Brain & Spine Announces New Specialty, New Name 2Health News:Maryland Brain & Spine Announces New Specialty, New Name 3Health News:Maryland Brain & Spine Announces New Specialty, New Name 4Health News:5th Annual Step for Hope 5K Run/Walk Event in Carol Stream, IL to Benefit Renowned Brain Aneurysm Foundation 2Health News:Advanced Fertility Center of Texas Is Proud to Announce That Our Lab Director Has Been Re-elected as The American College of Embryology President 2Health News:Zensah Releases Compression Sleeve To Relieve Ankle Pain and Plantar Fasciitis 2
... caffeine in coffee, tea or soft drinks increases blood ... may undermine efforts to control their disease, say scientists ... technology that measured participants glucose (sugar) levels on a ... psychologist at Duke and the lead author of the ...
... assisted living facility in violation of "Nicole,s Law" designed to ... protect vulnerable ... Atria Senior Living? That,s what members of the Campaign to Improve,Assisted ... facility at 15 Stevens Street in Andover was found in,violation of ...
... EPA campaign in January heightens awareness, tries to reduce ... an invisible radioactive gas that seeps into homes through ... monoxide poisoning, says the U.S. Environmental Protection Agency. , ... has designated January as National Radon Action Month. , ...
... people in Western society are suffering from auto-immune diseases. ... first important step in the search for targeted medicines. ... Universiteit Leuven joined forces and have elucidated the function ... They are the first to show that MALT1 ...
... how a particular family of diseases are passed down from ... severity of the disease differing widely. The research, funded by ... a child,s risk of developing a mitochondrial disease which can ... All human and animal cells contain many mitochondria, which are ...
... On January 23rd, Public,Citizen, a consumer group, filed ... and,Administration (FDA) requesting labeling changes for botulinum toxins,marketed ... and recorded studies in peer-reviewed journals have,documented the ... Surgery (ASAPS), the leading organization of board-certified,plastic surgeons ...
Cached Medicine News:Health News:Cutting caffeine may help control diabetes 2Health News:Activists Raise Alarm for Seniors, Deliver Carbon Monoxide Detectors to Atria Marland Place 2Health News:Radon Gas More Deadly Than Carbon Monoxide Poisoning 2Health News:A major step toward a more targeted treatment for auto-immune diseases? 2Health News:Mitochondrial 'bottleneck' cracked 2Health News:The American Society for Aesthetic Plastic Surgery Addresses the Safety of Botox 2
Keeler Professional Combi Retinoscope with new slimline handle and lithium or dry cell option....
300XL System, English (U.K. cord), 100-240 VAC....
Micro-mini fiber optic light....
Xenon technology achieves a higher efficiency than halogen light sources. Consequently they provide more light....
Medicine Products: